Table 1 Baseline characteristics of patients (n = 10)
Characteristics | Values |
|---|---|
Age (years; mean ± SD) | 54.2 ± 10.2 |
Gender (male/female) | 7/3 |
BMI (mean ± SD) | 23.7 ± 5.1 |
BP (mmHg/mean ± SD) | 158 ± 21/85 ± 14 |
Diabetic duration (years; mean ± SD) | 11.2 ± 7.9 |
Admission reason | HD initiation (all 10 patients) |
Hb (g/dL) | 8.5 ± 1.9 |
Alb (g/dL) | 2.7 ± 0.38 |
HbA1c (%; mean ± SD) | 5.7 ± 0.6 |
Glycated albumin (GA) (%; mean ± SD) | 17.4 ± 3.5 |
Fasting plasma glucose (mg/dl; mean ± SD) | 117 ± 22 |
Postprandial plasma glucose | 172 ± 20 |
Pre-HD plasma glucose | 184 ± 14 |
Previous anti-diabetic agent | (−): 7, alpha GI: 1, αGI + mitiglinide: 1, insulin:1 |
Dialysate | Kindary 2E (glucose: 100 mg/dl) |
Dialyser | Polysulfone (PS): 8, cellulose triacetate(CTA): 2 |
HD time | 3 h |
Quantity of blood (QB: ml/m) | 146 ± 11 |
Quantity of dialysate (QD: ml/m) | 500 |
KT/V | 0.73 ± 0.24 |
Vitamin D treatment | (+):3, (−):7 |
Residual kidney function | Urine volume 888 ± 461 (pre)→519 ± 185 (post) |
Glycosuria | (±):2 (+):5 (2+):3 |